- Home
- HES vs ALC Comparison
HES vs ALC Comparison
Compare HES & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HES
- ALC
- Stock Information
- Founded
- HES 1920
- ALC 1945
- Country
- HES United States
- ALC Switzerland
- Employees
- HES N/A
- ALC N/A
- Industry
- HES Integrated oil Companies
- ALC Ophthalmic Goods
- Sector
- HES Energy
- ALC Health Care
- Exchange
- HES Nasdaq
- ALC Nasdaq
- Market Cap
- HES 43.8B
- ALC 43.0B
- IPO Year
- HES N/A
- ALC N/A
- Fundamental
- Price
- HES $138.54
- ALC $88.27
- Analyst Decision
- HES Buy
- ALC Buy
- Analyst Count
- HES 9
- ALC 10
- Target Price
- HES $159.06
- ALC $107.00
- AVG Volume (30 Days)
- HES 2.1M
- ALC 1.5M
- Earning Date
- HES 07-30-2025
- ALC 08-19-2025
- Dividend Yield
- HES 1.44%
- ALC 0.25%
- EPS Growth
- HES 10.59
- ALC 6.66
- EPS
- HES 7.21
- ALC 2.25
- Revenue
- HES $12,270,000,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- HES N/A
- ALC $6.22
- Revenue Next Year
- HES $15.79
- ALC $7.16
- P/E Ratio
- HES $19.27
- ALC $39.07
- Revenue Growth
- HES 9.70
- ALC 3.80
- 52 Week Low
- HES $123.79
- ALC $80.48
- 52 Week High
- HES $161.69
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- HES 54.83
- ALC 48.31
- Support Level
- HES $137.42
- ALC $84.35
- Resistance Level
- HES $147.06
- ALC $87.90
- Average True Range (ATR)
- HES 2.88
- ALC 1.13
- MACD
- HES -0.14
- ALC 0.27
- Stochastic Oscillator
- HES 47.77
- ALC 51.20
About HES Hess Corporation
Hess is an independent oil and gas producer with key assets in the Bakken Shale, Guyana, the Gulf of Mexico, and Southeast Asia. At the end of 2024, the company reported net proved reserves of 1.44 billion barrels of oil equivalent. Net production averaged 481 thousand barrels of oil equivalent per day in 2024, at a ratio of 79% oil and natural gas liquids and 21% natural gas.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.